Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · IEX Real-Time Price · USD
4.500
0.00 (0.00%)
Jul 22, 2024, 9:41 AM EDT - Market open
Phio Pharmaceuticals Employees
As of December 31, 2023, Phio Pharmaceuticals had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,042,000
Market Cap
2.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
cbdMD | 52 |
NovaBay Pharmaceuticals | 26 |
Windtree Therapeutics | 20 |
InMed Pharmaceuticals | 13 |
Heart Test Laboratories | 12 |
Tivic Health Systems | 9 |
Aclarion | 6 |
Quoin Pharmaceuticals | 4 |
PHIO News
- 10 days ago - Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds - Newsfile Corp
- 14 days ago - Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762 - Newsfile Corp
- 17 days ago - Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds - Newsfile Corp
- 19 days ago - Phio Pharmaceuticals Announces Reverse Stock Split - Newsfile Corp
- 4 weeks ago - Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - Newsfile Corp
- 7 weeks ago - Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762 - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) - Newsfile Corp
- 2 months ago - Phio Pharmaceuticals Secures New Investor - GlobeNewsWire